Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genome search in celiac disease

L Greco1, G Corazza, M C Babron

  • 1Department of Pediatrics, University of Federico II, Naples, Italy.

American Journal of Human Genetics
|April 29, 1998
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Carbon sequestration potential of high-altitude afforestation in the Eastern Central Alps.

Journal of environmental management·2026
Same author

Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis).

The Journal of dermatological treatment·2024
Same author

PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Same author

Real-life experience with ixekizumab in plaque psoriasis: a multi-center, retrospective, 3-year study.

Expert opinion on biological therapy·2023
Same author

A single-centre, observational, retrospective, real-life study evaluating adalimumab biosimilar ABP 501 in the treatment of plaque-type psoriasis and psoriatic arthritis in originator-naïve patients and in patients undergoing non-medical switch from originator.

Current medical research and opinion·2021
Same author

Etanercept biosimilar SB4 in the treatment of plaque-type psoriasis and psoriatic arthritis: a single-centre, observational, retrospective, real-life study.

The British journal of dermatology·2019

Genetic factors beyond HLA influence celiac disease (CD) susceptibility. This study identified a risk factor on chromosome 5qter for both symptomatic and silent CD, and another on 11qter potentially differentiating forms.

Area of Science:

  • Genetics
  • Gastroenterology
  • Immunology

Background:

  • Celiac disease (CD) is an autoimmune disorder triggered by gluten ingestion, affecting the small intestine.
  • Human Leukocyte Antigen (HLA) genes are known major genetic risk factors for CD, but they do not account for all heritable susceptibility.
  • Identifying additional genetic loci is crucial for a comprehensive understanding of CD pathogenesis.

Purpose of the Study:

  • To conduct a systematic genome-wide screening to identify novel genetic risk factors for celiac disease.
  • To investigate genetic factors contributing to both symptomatic and silent forms of CD.
  • To validate previously reported genetic regions associated with CD susceptibility.

Main Methods:

  • Genome-wide linkage analysis was performed using 281 genetic markers in 110 affected sib pairs and their parents.

Related Experiment Videos

  • Initial analysis focused on 39 pairs with symptomatic CD in both siblings, followed by replication in 71 pairs with mixed symptomatic/silent CD phenotypes.
  • Systematic screening aimed to identify and confirm linkage regions associated with CD genetic risk.

    • Main Results:

    • Beyond the established HLA loci, a significant genetic risk factor was identified on chromosome 5qter, implicated in both symptomatic and silent CD.
    • A distinct genetic factor on chromosome 11qter was suggested to potentially differentiate between symptomatic and silent CD phenotypes.
    • No previously published genetic regions associated with CD were confirmed in this screening study.

    Conclusions:

    • The study implicates novel genetic loci on 5qter and 11qter in the complex genetic architecture of celiac disease.
    • The identified 5qter locus contributes to susceptibility across different clinical presentations of CD.
    • The 11qter locus may play a role in modulating disease phenotype, distinguishing symptomatic from silent forms.